Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess

Rhea-AI Summary

Bio-Techne Corporation (NASDAQ:TECH) has launched Abby, an advanced chemiluminescence system designed to automate the traditional Western blotting process. Abby features picogram-level sensitivity and the innovative RePlex™ technology, enabling sequential immunoassays. Additionally, the new Compass software enhances data analysis efficiency. The company also announced the upcoming Stellar™ NIR and IR modules for Jess™, which aim to elevate fluorescence Western blotting sensitivity. Bio-Techne emphasizes that these products contribute to faster, more reproducible results, essential for modern research environments.

Positive

• Launch of Abby system providing picogram-level sensitivity.
• RePlex™ technology enables efficient sequential immunoassays.
• New Compass software improves data analysis capabilities.
• Upcoming Stellar™ modules enhance fluorescence sensitivity.

Negative

• None.

MINNEAPOLIS, April 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western blotting.  This latest addition to the Simple Western product family offers picogram-level sensitivity through chemiluminescence detection along with the ability to perform sequential immunoassays using RePlex™.  Abby is accompanied by the latest version of Compass software for Simple Western that adds to its publication-ready data analysis tools extensive lane view annotation capabilities that save hours typically spent editing in other programs.  In addition, ProteinSimple has announced the pending release of Stellar™ NIR and IR modules for Jess™ which will set a new industry standard for fluorescence Western blotting sensitivity.

ProteinSimple's Simple Western systems are automated, hands-free, blot-free, Western platforms that deliver fully analyzed and quantitated results on 24 samples in as little as 3 hours.  The RePlex™ feature, now available on the Abby and Jess systems, enables detection of phosphorylated target and total target levels as well as the ability to multiplex multiple targets in consecutive immunoassays.  RePlex also allows total protein detection to be performed within the same capillary as an immunoassay, replacing the need to rely on variable biological loading controls and resulting in consistent normalized immunoassay data that meets the highest publication requirements set by top level journals and grant agencies. 

The Stellar fluorescence modules for Jess provide low picogram sensitivity that is in the same range as Simple Western's unparalleled chemiluminescence detection. 

"We are excited about the addition of Abby to an already powerful Simple Western portfolio," commented Steve Crouse, Vice President and General Manager of Bio-Techne's Analytical Solutions Division.  "In addition, the unmatched fluorescence sensitivity of the Stellar modules will open up new experimental possibilities in Western analysis."

Traditional Western blots have many drawbacks in fast-moving research settings including being slow, labor intensive and lacking reproducibility. Simple Western systems overcome the drawbacks of traditional western blots by providing automation, rapid time to quantitative results, and reproducibility.  Proprietary RePlex technology removes the labor and inconsistency involved with traditional stripping and reprobing by leveraging Simple Western's unique sample immobilization chemistry and automating antibody removal and immunoassay steps.    

"The Abby system for Simple Western leverages the unique RePlex capability which has dramatically sped up the workflows of our customers while lowering their consumables cost," stated Dave Eansor, President of Bio-Techne's Protein Sciences Segment. "I'm thrilled to be able to also announce the pending arrival of Stellar modules that will also change how scientists think about Western analysis."

The Abby system from Bio-Techne is intended for research use only. To learn more, visit: https://www.proteinsimple.com/abby.html

About Bio-Techne Corporation (NASDAQ: TECH)

Contact: David Clair, Senior Director, Investor Relations & Corporate Development

david.clair@bio-techne.com

612-656-4416

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-announces-commercial-release-of-abby-automated-western-system-for-simple-western-and-introduces-stellar-modules-for-jess-301264728.html

SOURCE Bio-Techne Corporation

FAQ

What is the significance of the Abby system announced by Bio-Techne on April 8, 2021?

The Abby system automates traditional Western blotting, offering picogram-level sensitivity and improved efficiency in immunoassays, revolutionizing research workflows.

How does Abby's RePlex technology benefit researchers using Bio-Techne's products?

RePlex technology allows for simultaneous detection of multiple targets, reducing the need for traditional stripping and reprobing, ensuring consistent and reproducible immunoassay results.

What improvements does the latest version of Compass software bring for Simple Western users?

The latest Compass software version enhances data analysis with extensive lane view annotation capabilities, saving time in editing and ensuring publication-ready results.

When are the Stellar NIR and IR modules for Jess expected to be released?

The Stellar modules are pending release and are designed to set a new standard for sensitivity in fluorescence Western blotting.